Thousands of Patients Left Without Critical Drug for Nearly a Year – Now Comes the Good News
Health maintenance organizations have received a British alternative to the drug 'Slow Dralin' in 80 mg dosage, after Maariv exposed months of shortage. The drug is intended, among other things, for migraines, high blood pressure, and tremors; availability should be checked and treatment should not be changed without consultation.
Health maintenance organizations in Israel have received a British alternative to the drug 'Slow Dralin' in 80 mg dosage, after Maariv exposed months of shortage. The drug, intended among other things for migraines, high blood pressure, and tremors, contains propranolol hydrochloride in extended-release form. During the shortage, patients suffered from recurring migraine attacks, and doctors were forced to switch to other preparations. The new alternative does not guarantee immediate availability in every pharmacy, and stock should be checked. Treatment should not be changed without medical consultation, and caution should be exercised in patients with asthma or heart problems.
Thousands of Patients Left Without Critical Drug for Nearly a Year – Now Comes the Good News